Growth Metrics

Bio-Rad Laboratories (BIO) Goodwill (2016 - 2026)

Bio-Rad Laboratories has reported Goodwill over the past 18 years, most recently at $577.1 million for Q1 2026.

  • Quarterly Goodwill rose 39.19% to $577.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $577.1 million through Mar 2026, up 39.19% year-over-year, with the annual reading at $579.8 million for FY2025, 41.24% up from the prior year.
  • Goodwill was $577.1 million for Q1 2026 at Bio-Rad Laboratories, roughly flat from $579.8 million in the prior quarter.
  • Over five years, Goodwill peaked at $579.8 million in Q4 2025 and troughed at $160.5 million in Q2 2025.
  • The 5-year median for Goodwill is $411.5 million (2023), against an average of $417.7 million.
  • The largest YoY upside for Goodwill was 41.24% in 2025 against a maximum downside of 61.05% in 2025.
  • A 5-year view of Goodwill shows it stood at $406.5 million in 2022, then increased by 1.75% to $413.6 million in 2023, then dropped by 0.75% to $410.5 million in 2024, then skyrocketed by 41.24% to $579.8 million in 2025, then fell by 0.47% to $577.1 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Goodwill are $577.1 million (Q1 2026), $579.8 million (Q4 2025), and $578.7 million (Q3 2025).